Read + Share
Zeidan AM, Fenaux P, Gobbi M, Mayer J, et al. Prospective comparison of outcomes with azacitidine and decitabine in patients
with AML ineligible for intensive chemotherapy. Blood 2022;140:285-289.
PMID: 35507690
|
 |
|
Zeidan AM, Fenaux P, Gobbi M, Mayer J, et al. Prospective comparison of outcomes with azacitidine and decitabine in patients
with AML ineligible for intensive chemotherapy. Blood 2022;140:285-289.
PMID: 35507690
|
|
|
|